COVID-19 research: promising tracks leading to uro-oncology.
作者信息
Tamás Fazekas, Tibor Szarvas, Anita Csizmarik, Boris Hadaschik, Péter Nyirády
机构信息
Department of Urology, Semmelweis University, Budapest, Hungary.
Department of Urology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.
出版信息
Int Urol Nephrol. 2020 Jun;52(6):995-997. doi: 10.1007/s11255-020-02490-2. Epub 2020 May 11.
Abstract
摘要
相似文献
1
COVID-19 research: promising tracks leading to uro-oncology.新冠病毒疾病研究：通往泌尿肿瘤学的前景光明的研究方向。
Int Urol Nephrol. 2020 Jun;52(6):995-997. doi: 10.1007/s11255-020-02490-2. Epub 2020 May 11.
2
The JCF in the Time of COVID-19.新冠疫情时期的日本临床肿瘤学会（JCF）
J Card Fail. 2020 Jun;26(6):447. doi: 10.1016/j.cardfail.2020.06.004.
3
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?新冠疫情对欧洲泌尿外科肿瘤学实践的影响：我们未来面临何种活动负担？
Eur Urol. 2020 Jul;78(1):124-126. doi: 10.1016/j.eururo.2020.04.036. Epub 2020 Apr 24.
4
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.COVID-19大流行期间的肿瘤护理服务：研究创新与结果的契机。
JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28.
5
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.面对新冠疫情时胃肠道肿瘤学的实践调整：肿瘤学专家关于将患者风险降至最低的建议
JCO Oncol Pract. 2020 Jul;16(7):383-388. doi: 10.1200/OP.20.00239. Epub 2020 Apr 30.
6
Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.为肿瘤临床医生制定以患者为中心的框架，以应对 COVID-19 大流行期间癌症护理中的不确定性。
Curr Treat Options Oncol. 2020 Oct 29;21(12):99. doi: 10.1007/s11864-020-00795-z.
7
Effect of the COVID-19 pandemic on cancer treatment and research.2019冠状病毒病大流行对癌症治疗及研究的影响。
Lancet Haematol. 2020 Jun;7(6):e432-e435. doi: 10.1016/S2352-3026(20)30123-X. Epub 2020 Apr 24.
8
"Long covid": the Dutch response.“长期新冠”：荷兰的应对措施。
BMJ. 2020 Aug 14;370:m3202. doi: 10.1136/bmj.m3202.
9
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.从医生作为患者的角度：应对新冠长期症状的宣言。
BMJ. 2020 Sep 15;370:m3565. doi: 10.1136/bmj.m3565.
10
Adapting the Educational Environment for Cardiovascular Fellows-in-Training During the COVID-19 Pandemic.在新冠疫情期间为心血管专科住院医师调整教育环境
J Am Coll Cardiol. 2020 May 26;75(20):2630-2634. doi: 10.1016/j.jacc.2020.04.013. Epub 2020 Apr 15.
引用本文的文献
1
Urological complications of COVID-19: a systematic review.新型冠状病毒肺炎的泌尿系统并发症：系统评价。
Int Braz J Urol. 2023 Jan-Feb;49(1):24-40. doi: 10.1590/S1677-5538.IBJU.2022.0281.
2
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.跨膜丝氨酸蛋白酶2（TMPRSS2）在2019冠状病毒病和前列腺癌中的关键作用。
Future Oncol. 2020 Sep;16(27):2029-2033. doi: 10.2217/fon-2020-0571. Epub 2020 Jul 13.
本文引用的文献
1
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era.欧洲泌尿外科学会指南办公室快速反应小组：全组织协作努力，使欧洲泌尿外科学会指南推荐适应 2019 年冠状病毒病时代。
Eur Urol. 2020 Jul;78(1):21-28. doi: 10.1016/j.eururo.2020.04.056. Epub 2020 Apr 27.
2
and COVID-19: Serendipity or Opportunity for Intervention?新冠病毒与心血管疾病：偶然还是干预的机会？
Cancer Discov. 2020 Jun;10(6):779-782. doi: 10.1158/2159-8290.CD-20-0451. Epub 2020 Apr 10.
3
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
4
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
5
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.欧洲泌尿外科学会非肌肉浸润性膀胱癌（TaT1 和原位癌）指南 - 2019 年更新版。
Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20.
6
The Humoral Immune Response to BCG Vaccination.BCG 疫苗接种的体液免疫应答。
Front Immunol. 2019 Jun 11;10:1317. doi: 10.3389/fimmu.2019.01317. eCollection 2019.
7
Non-specific effects of BCG vaccine on viral infections.卡介苗疫苗对病毒感染的非特异性作用。
Clin Microbiol Infect. 2019 Dec;25(12):1473-1478. doi: 10.1016/j.cmi.2019.04.020. Epub 2019 May 2.
8
[Molecular subtypes and perspectives of targeted therapies in prostate cancer].[前列腺癌的分子亚型及靶向治疗前景]
Orv Hetil. 2019 Feb;160(7):252-263. doi: 10.1556/650.2019.31315.
9
Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations.疫苗的非特异性效应——以卡介苗为例：从观察到验证。
Front Immunol. 2018 Dec 4;9:2869. doi: 10.3389/fimmu.2018.02869. eCollection 2018.
10
Heterologous effects of infant BCG vaccination: potential mechanisms of immunity.婴儿卡介苗接种的异源效应：免疫的潜在机制。
Future Microbiol. 2018 Aug;13(10):1193-1208. doi: 10.2217/fmb-2018-0026. Epub 2018 Aug 17.
Zotero 插件